Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India
Abstract Background Parenteral artesunate is the treatment of choice for severe malaria. It is safe, efficacious and well tolerated anti-malarial. However, delayed haemolysis has been reported in travellers, non-immune individuals and in African children. Methods A prospective, observational study w...
Main Authors: | Deepali Savargaonkar, Manoj Kumar Das, Amar Verma, Jeevan K. Mitra, C. P. Yadav, Bina Srivastava, Anupkumar R. Anvikar, Neena Valecha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12936-020-3120-4 |
Similar Items
-
Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia
by: Rolling Thierry, et al.
Published: (2012-05-01) -
Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence
by: Khalid Rehman, et al.
Published: (2014-12-01) -
Artesunate-amodiaquine fixed dose combination for the treatment of <it>Plasmodium falciparum </it>malaria in India
by: Anvikar Anupkumar R, et al.
Published: (2012-03-01) -
Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa
by: Julien Zwang, et al.
Published: (2017-06-01) -
BENEFICIAL EFFECTS OF THE WHOLE-BODY CRYOTHERAPY ON SPORT HAEMOLYSIS
by: Gianvico Melzi d’Eril, et al.
Published: (2009-07-01)